Indianapolis, IN, United States of America

Binh Nguyen

This inventor holds 1 USPTO granted patent. Top assignee: Endocyte, Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Binh Nguyen. Retrieved from https://idiyas.com/inventor/binh-nguyen-qld2nkwg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Binh Nguyen: Innovator in Cancer Treatment

Introduction

Binh Nguyen is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of cancer treatment through his innovative research and development.

Latest Patents

Binh Nguyen holds 1 patent for his work on methods of treating cancer. His patent describes methods and compositions for treating epithelial tumors with a folate-vinca conjugate in combination with at least one other chemotherapeutic agent. The tumors targeted by his research include ovarian, endometrial, and non-small cell lung cancer tumors, specifically addressing both platinum-resistant and platinum-sensitive ovarian tumors.

Career Highlights

Binh Nguyen is currently employed at Endocyte, Inc., where he continues to advance his research in cancer therapies. His work has the potential to significantly impact the treatment options available for patients suffering from various types of cancer.

Collaborations

Binh has collaborated with notable colleagues such as Joseph Anand Reddy and Christopher Paul Leamon, contributing to a dynamic research environment focused on innovative cancer treatments.

Conclusion

Binh Nguyen's contributions to cancer treatment through his patented methods highlight his role as an important figure in medical innovation. His work at Endocyte, Inc. and collaborations with other professionals further emphasize his commitment to improving patient outcomes in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…